Home LiteratureArticle Details
PMID: 6188863 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.

Journal of virology ·Vol. 46 ·No. 2 ·1983-05-00 ·Pages 466-74

Emini EA, Kao SY, Lewis AJ, Crainic R, Wimmer E

Abstract

Antibody-mediated poliovirus neutralization was studied by using a series of 13 monospecific neutralizing antibodies. These antibodies were found to recognize seven individual viral epitopes, several of which functionally overlap one another. Each epitope was capable of undergoing variation so that the variant virus was no longer capable of being neutralized by antibody directed against that epitope. The measured degree of variation for each site varied from -3.1 to -4.2 log10 variant PFU per wild-type PFU. Under nonsaturating but neutralizing conditions, the antibodies, with the exception of those directed to one specific epitope, failed to completely inhibit the virion's binding to the cell. Similarly, none of the neutralizing antibodies completely inhibited viral penetration, but all prevented virus-specific transcription. A strong correlation was established between the binding of each of the neutralizing antibodies, with one exception, to the virion and a significant shift in the virion's pI from 7.0 to ca. 4.0.

MeSH Terms
Antibodies, Monoclonal Antibodies, Viral/immunology Antigens, Viral/immunology Epitopes Genetic Variation Isoelectric Point Neutralization Tests Poliovirus/genetics,immunology,physiology Transcription, Genetic Virus Replication
Chemicals
Antibodies, Monoclonal Antibodies, Viral Antigens, Viral Epitopes
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Emini E A
Kao S Y
Lewis A J
Crainic R
Wimmer E
References (23)
23 references, click to expand
  1. Characterization of type 1 poliovirus by electrophoretic analysis.
    Virology. 1971 Jun;44(3):554-68 PMID: 4332969
  2. The interaction of neutralized poliovirus with HeLa cells. I. Adsorption.
    Virology. 1967 Feb;31(2):238-47 PMID: 4289999
  3. Early alteration of poliovirus in infected cells and its specific inhibition.
    J Gen Virol. 1975 Jun;27(3):329-42 PMID: 167116
  4. Continuous cultures of fused cells secreting antibody of predefined specificity.
    Nature. 1975 Aug 7;256(5517):495-7 PMID: 1172191
  5. Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction.
    Virology. 1976 Feb;69(2):500-10 PMID: 176784
  6. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.
    Eur J Immunol. 1976 Jul;6(7):511-9 PMID: 825377
  7. Primary structure, gene organization and polypeptide expression of poliovirus RNA.
    Nature. 1981 Jun 18;291(5816):547-53 PMID: 6264310
  8. A hybridoma cell line secreting antibody to poliovirus type 3 D-antigen: detection in virus harvest of two D-antigen populations.
    J Gen Virol. 1981 Jun;54(Pt 2):437-42 PMID: 6270261
  9. A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.
    Virology. 1981 Nov;115(1):211-5 PMID: 6270899
  10. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
    J Gen Virol. 1981 Oct;56(Pt 2):337-47 PMID: 6273502
  11. Production and potential use of monoclonal antibodies against polio viruses.
    Dev Biol Stand. 1981;50:221-8 PMID: 6281107
  12. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
    Dev Biol Stand. 1981;50:229-34 PMID: 6176486
  13. [Structural polypeptide VP1 in poliovirus type 1 induced by neutralizing antibodies].
    C R Seances Acad Sci III. 1982 Jan 11;294(2):91-4 PMID: 6282399
  14. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
    Infect Immun. 1982 May;36(2):841-3 PMID: 6282759
  15. Cleavage sites within the poliovirus capsid protein precursors.
    J Virol. 1982 Jan;41(1):340-4 PMID: 6283126
  16. Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3.
    Lancet. 1982 Jul 17;2(8290):122-4 PMID: 6123838
  17. Identification of the initiation site of poliovirus polyprotein synthesis.
    J Virol. 1982 Jun;42(3):1017-28 PMID: 6284987
  18. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.
    J Virol. 1982 Sep;43(3):997-1005 PMID: 6183443
  19. Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein.
    Virology. 1983 Jan 15;124(1):144-51 PMID: 6186073
  20. Principles of immunization as applied to poliomyelitis and influenza.
    Am J Public Health Nations Health. 1953 Nov;43(11):1384-98 PMID: 13104698
  21. Studies on the interactions of poliomyelitis virus, antibody, and host cells in tissue culture system.
    Virology. 1958 Oct;6(2):424-47 PMID: 13593181
  22. Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients.
    Infect Immun. 1982 Jul;37(1):46-53 PMID: 6179881
  23. Picornavirus receptors and picornavirus multiplication in human-mouse hybrid cell lines.
    Virology. 1973 Aug;54(2):515-24 PMID: 4353524
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1983-05-00
Pages
466-74
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC255148
Subset
IM
Grants
NIAID NIH HHS · AI-06485 · United States
NIAID NIH HHS · AI-15122 · United States
NCI NIH HHS · CA-28146 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]